New hope for tough lymphomas: experimental drug shows promise in Mid-Stage trial
NCT ID NCT04842877
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called valemetostat tosylate in people with B-cell lymphoma whose cancer has returned or not responded to prior treatments. About 141 participants will receive the drug to see if it can shrink tumors. The goal is to find a new option for hard-to-treat lymphomas.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGGRESSIVE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A.Z. Sint Jan AV
Bruges, 8000, Belgium
-
CH Tourelle Peltzer
Verviers, 4800, Belgium
-
CH d'Avignon
Avignon, 84000, France
-
CH de la Côte Basque
Bayonne, 64109, France
-
CHU Hôtel Dieu
Nantes, 44093, France
-
CHU Mont-Godinne
Yvoir, Belgium
-
CHU Pontchaillou
Rennes, 35003, France
-
CHU d'Estaing
Clermont-Ferrand, 63000, France
-
CHU de Dijon
Dijon, 21034, France
-
CHU de Montpellier
Montpellier, 34295, France
-
Ch Metropole Savoie - Site Chambery
Chambéry, 73000, France
-
Ch de Bretagne Atlantique -
Vannes, 56017, France
-
Chd de Vendee
La Roche-sur-Yon, 85925, France
-
Clinique Victor Hugo
Le Mans, 72000, France
-
Emmanuel Bachy
Pierre-Bénite, 69495, France
-
François Lemonnier
Créteil, 94010, France
-
Gh Region Mulhouse Et Sud Alsace
Mulhouse, 68070, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut Paoli Calmette
Marseille, 13273, France
-
Institut d'Hématologie de Basse Normandie
Caen, 14076, France
-
Service des Maladies du Sang - CHRU de Lille
Lille, 59037, France
-
University Hospital Gent
Ghent, 9000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells plus a checkpoint drug outsmart lymphoma?
- A shot at safer CAR t: early brain protection for lymphoma patients?
- Can a Triple-Drug combo wipe out Slow-Growing lymphomas?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Engineered immune cells take aim at Hard-to-Treat lymphomas
- A simple blood test may reveal hidden infertility risk in young cancer survivors